Breast cancers expressing Estrogen Receptor alpha (ERα, encoded by the ESR1 gene) are dependent on estrogen-induced signaling for proliferation, and they are highly susceptible to an array of hormonal interventions targeting this pathway. Here, ESR1 is linked to breast carcinoma.